NICE launches review of methods and processes for health technology evaluation
Stakeholders can comment until 13 October on the most wide-ranging and comprehensive review NICE has ever carried out. The public consultations cover proposed changes to the way NICE develops recommendations across its health technology evaluation programmes and proposals to clarify the topic selection and routing criteria used to determine what treatments, devices or diagnostics are selected for NICE guidance development.
Related stories
- Lipoprotein (a) disorder gets SNOMED codes
- Would you like to update your knowledge of lipid management and have the opportunity to liaise with others working in this area?
- Familial Hypercholesterolaemia Gene Testing One-Day Online Workshop - Dates for 2023
- New SNOMED Codes for FH DNA test results!
- Healthcare Professional Dietary Survey Prize Draw 2022
- Opportunity to join the NICE CG181 guideline committee
- The Essential Cholesterol Programme for Primary Care
- Add on to take back control. Do we have the solutions to the gaps in our lipid treatment pathway?
- Familial Hypercholesterolaemia: from Epidemiology to Genetics – a paradigm shift?
- The role of Lp(a) and oxPLs in atherosclerosis